Ali Badiee

Cited by

	All	Since 2019
Citations	3425	2267
h-index	35	28
i10-index	82	72

500

250

125

375

2008200920102011201220132014201520162017201820192020202120222023202416 33 36 39 73 65 100 135 182 202 244 293 378 465 468 488 173

Public access

View all

3 articles

2 articles

available

not available

Based on funding mandates

Co-authors

Mahmoud Reza JaafariProf. of Pharmaceutics and Pharmaceutical NanotechnologyVerified email at mums.ac.ir
Ali Khamesipourprofessor of immunology, Tehran University of Medical SciencesVerified email at tums.ac.ir
Amin Reza Nikpoor, Ph.D. Postdoctora...Queens universityVerified email at queensu.ca
Seyedeh Hoda AlavizdaehNanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, MashhadVerified email at mums.ac.ir
Seyed Amir JalaliImmunology Department, Medical School, Shahid Beheshti university of medical sciencesVerified email at sbmu.ac.ir
Leila ArabiAssistant Professor, Pharmaceutical Nanotechnology, Mashhad University of Medical SciencesVerified email at mums.ac.ir
Mona Yazdani, Ph.D.Postdoctoral Research Fellow, Centre for Cancer ImmunologyVerified email at soton.ac.uk
Vahid Heravi SharghThe University of ManchesterVerified email at uon.edu.au
Mohammad MashreghiPhD in Pharmaceutical Nanotechnology, Mashhad University of Medical SciencesVerified email at mums.ac.ir
Amirhossein SahebkarMashhad University of Medical SciencesVerified email at mums.ac.ir
Fatemeh MosaffaProfessor of Pharmaceutical Biotechnology, Mashhad University of Medical SciencesVerified email at mums.ac.ir
Zahra SaberiNanotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, IranVerified email at mums.ac.ir
Mohsen TafaghodiNanotechnology Resarch Center and School of Pharmacy, Mashhad University of Medical SciencesVerified email at mums.ac.ir
Atefeh RazazanWVU Medical SchoolVerified email at hsc.wvu.edu
Javad BehravanUniversity of WaterlooVerified email at uwaterloo.ca
Shiva GolmohammadzadehNanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, IranVerified email at mums.ac.ir
Khalil AbnousPharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, IranVerified email at mums.ac.ir
Kayvan SadriNuclear Medicine Research Center, Mashhad University of Medical Sciences, IranVerified email at mums.ac.ir
Zahra Gholizadeh, DVM, PhDDepartment of Bioscience, AstraZenecaVerified email at astrazeneca.com
Mahdi HatamipourDepartment of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical SciencesVerified email at mums.ac.ir

Ali Badiee

School of Pharmacy, Mashhad University of Medical Sciences

Verified email at mums.ac.ir

Vaccine delivery Drug delivery Lipid-based delivery sysytems


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin L Arabi, A Badiee, F Mosaffa, MR Jaafari Journal of controlled release 220, 275-286, 2015	175	2015
Crystal habit modifications of ibuprofen and their physicomechanical characteristics HA Garekani, F Sadeghi, A Badiee, SA Mostafa, AR Rajabi-Siahboomi, ... Drug development and industrial pharmacy 27 (8), 803-809, 2001	168	2001
The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in … MR Jaafari, A Badiee, A Khamesipour, A Samiei, D Soroush, MT Kheiri, ... Vaccine 25 (32), 6107-6117, 2007	116	2007
Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas M Amin, A Badiee, MR Jaafari International journal of pharmaceutics 458 (2), 324-333, 2013	110	2013
Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends A Badiee, VH Shargh, A Khamesipour, MR Jaafari Vaccine 31 (5), 735-749, 2013	98	2013
The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen A Badiee, A Khamesipour, A Samiei, D Soroush, VH Shargh, MT Kheiri, ... Experimental parasitology 132 (4), 403-409, 2012	88	2012
Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region M Amin, M Mansourian, GA Koning, A Badiee, MR Jaafari, ... Journal of Controlled Release 220, 308-315, 2015	84	2015
Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205 A Badiee, N Davies, K McDonald, K Radford, H Michiue, D Hart, M Kato Vaccine 25 (25), 4757-4766, 2007	82	2007
Leishmania major: immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes A Badiee, MR Jaafari, A Khamesipour Experimental parasitology 115 (2), 127-134, 2007	82	2007
Redox-sensitive nanoscale drug delivery systems for cancer treatment E Mirhadi, M Mashreghi, MF Maleki, SH Alavizadeh, L Arabi, A Badiee, ... International journal of pharmaceutics 589, 119882, 2020	76	2020
P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer S Shariat, A Badiee, SA Jalali, M Mansourian, M Yazdani, SA Mortazavi, ... Cancer letters 355 (1), 54-60, 2014	73	2014
Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model SA Moosavian, K Abnous, A Badiee, MR Jaafari Colloids and Surfaces B: Biointerfaces 139, 228-236, 2016	72	2016
Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN M Mansourian, A Badiee, SA Jalali, S Shariat, M Yazdani, M Amin, ... Immunology letters 162 (1), 87-93, 2014	68	2014
Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis AA Momtazi-Borojeni, MR Jaafari, A Badiee, M Banach, A Sahebkar BMC medicine 17, 1-15, 2019	66	2019
Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA) H Firouzmand, A Badiee, A Khamesipour, VH Shargh, SH Alavizadeh, ... Acta tropica 128 (3), 528-535, 2013	63	2013
Coencapsulation of CpG Oligodeoxynucleotides with Recombinant Leishmania major Stress-Inducible Protein 1 in Liposome Enhances Immune Response and … A Badiee, MR Jaafari, A Samiei, D Soroush, A Khamesipour Clinical and vaccine immunology 15 (4), 668-674, 2008	62	2008
MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer P Zamani, JG Navashenaq, AR Nikpoor, M Hatamipour, RK Oskuee, ... Journal of controlled release 303, 223-236, 2019	61	2019
Preparation, characterization and in vivo evaluation of alginate-coated chitosan and trimethylchitosan nanoparticles loaded with PR8 influenza virus for nasal immunization J Mosafer, AH Sabbaghi, A Badiee, S Dehghan, M Tafaghodi Asian Journal of Pharmaceutical Sciences 14 (2), 216-221, 2019	61	2019
Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis VH Shargh, MR Jaafari, A Khamesipour, I Jaafari, SA Jalali, A Abbasi, ... Vaccine 30 (26), 3957-3964, 2012	61	2012
Long-term generation of antiPCSK9 antibody using a nanoliposome-based vaccine delivery system AA Momtazi-Borojeni, MR Jaafari, A Badiee, A Sahebkar Atherosclerosis 283, 69-78, 2019	56	2019

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors